Delivery Order SPE2DR25D1100-SPE2DR26FCU6A
- Not listed
- The Defense Logistics Agency awarded a $1,982.30 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextrose on December 3, 2025, with a completion date of December 4, 2025. This firm fixed price delivery order represents a routine pharmaceutical procurement under a non-set-aside, competitively awarded vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical vendor serving military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.38 to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses on December 4, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,728.09 to AmerisourceBergen Drug Corp for the supply of Cefazolin 3 G/50 ML with dextrose solution, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.38 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML-Dextroses, an antibiotic medication used in clinical settings. This firm fixed price delivery order, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,840.77 to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose solution, with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,545.07 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Cefazolin 2 G/50 ML in dextrose solutions. This firm fixed-price contract, which is not set-aside designated, is scheduled for completion by November 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,638.08 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous form. The contract employs firm fixed price terms with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,189.38 to supply Cefazolin 2 G/50 ML with Dextrose, an antibiotic medication commonly used in military and federal healthcare settings. This firm fixed-price delivery order, issued on November 25, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.38 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50mL with dextroses, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This non-set-aside, firm fixed-price delivery order was awarded on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.75 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML in dextrose solution. The contract employs firm fixed price terms and is scheduled for ultimate completion on July 30, 2025, just one day after the award date of July 29, 2025. This delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU6ADelivery Order
The Defense Logistics Agency awarded a $2,954.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses, with a completion date of December 15, 2025. This non-set-aside competitive award was issued on December 12, 2025, and represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order supports the federal military healthcare supply chain by providing a critical antibiotic pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a prime vendor for the Defense Logistics Agency's medical supply operations, supporting military and veteran healthcare systems. The company's comprehensive IDC vehicle enables flexible fulfillment of pharmaceutical and medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/11/25 |